Rankings
▼
Calendar
IVVD Q3 2025 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$257M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
+41.2% YoY
Gross Profit
$12M
91.7% margin
Operating Income
-$11M
-84.0% margin
Net Income
-$10M
-79.7% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+11.4%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$139M
Total Liabilities
$46M
Stockholders' Equity
$93M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$9M
+41.2%
Gross Profit
$12M
$8M
+41.8%
Operating Income
-$11M
-$62M
+82.3%
Net Income
-$10M
-$61M
+82.8%
Revenue Segments
Product
$13M
100%
← FY 2025
All Quarters
Q4 2025 →